Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Alcoholism and ADHD
NCT00261872Phase 4Completed
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in alcohol use disorder (AUD), attention deficit hyperactivity disorder (ADHD), sponsored by National Institute on Alcohol Abuse and Alcoholism. Started Dec 2005; status: completed.
02
Drugs
methylphenidate
03
Conditions
alcohol use disorder (AUD)attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00261872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261872.